Type 1 Interferons and NK Cells Limit Murine Cytomegalovirus Escape from the Lymph Node Subcapsular Sinus

PLoS Pathogens

Volumn 12, Issue 12, 2016, Pages

  Farrell, Helen E ^a   Bruce, Kimberley ^a   Lawler, Clara ^a   Cardin, Rhonda D ^b   Davis Poynter, Nicholas J ^a   Stevenson, Philip G ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; INTERFERON; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FIBROBLAST; LUCIFERASE ASSAY; LYMPH NODE; LYMPH NODE SUBCAPSULAR SINUS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; RETICULUM CELL; SENSITIVITY ANALYSIS; TISSUE INJURY; VIRUS REPLICATION; ANIMAL; HERPES VIRUS INFECTION; IMMUNOLOGY; INNATE IMMUNITY; MACROPHAGE; MUROMEGALOVIRUS; VIROLOGY;

ANIMALS; HERPESVIRIDAE INFECTIONS; IMMUNITY, INNATE; INTERFERON TYPE I; KILLER CELLS, NATURAL; LYMPH NODES; MACROPHAGES; MICE; MUROMEGALOVIRUS;

EID: 85007564211     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006069     Document Type: Article

References (55)

1. Britt W, Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr Top Microbiol Immunol. 2008; 325: 417–470. 18637519
2. Krause PR, Bialek SR, Boppana SB, Griffiths PD, Laughlin CA, et al. Priorities for CMV vaccine development. Vaccine. 2013; 32: 4–10. doi: 10.1016/j.vaccine.2013.09.04224129123
3. McGeoch DJ, Rixon FJ, Davison AJ, Topics in herpesvirus genomics and evolution. Virus Res. 2006; 117: 90–104. doi: 10.1016/j.virusres.2006.01.00216490275
4. Collins TM, Quirk MR, Jordan MC, Biphasic viremia and viral gene expression in leukocytes during acute cytomegalovirus infection of mice. J Virol. 1994; 68: 6305–6311. 8083970
5. Stoddart CA, Cardin RD, Boname JM, Manning WC, Abenes GB, et al. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol. 1994; 68: 6243–6253. 8083964
6. Farrell HE, Davis-Poynter N, Bruce K, Lawler C, Dolken L, et al. Lymph node macrophages restrict murine cytomegalovirus dissemination. J Virol. 2015; 89: 7147–7158. doi: 10.1128/JVI.00480-1525926638
7. Hume DA, The mononuclear phagocyte system. Curr Opin Immunol. 2006; 18: 49–53. doi: 10.1016/j.coi.2005.11.00816338128
8. Gonzalez SF, Pitcher LA, Mempel T, Schuerpf F, Carroll MC, B cell acquisition of antigen in vivo. Curr Opin Immunol. 2009; 21: 251–257. doi: 10.1016/j.coi.2009.05.01319515546
9. Kuka M, Iannacone M, The role of lymph node sinus macrophages in host defense. Ann N Y Acad Sci. 2014; 1319: 38–46. doi: 10.1111/nyas.1238724592818
10. Davis KJ, Anderson AO, Geisbert TW, Steele KE, Geisbert JB, et al. Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells. Arch Pathol Lab Med. 1997; 121: 805–819. 9278608
11. Anderson AO, Shaw S, T cell adhesion to endothelium: the FRC conduit system and other anatomic and molecular features which facilitate the adhesion cascade in lymph node. Semin Immunol. 1993; 5: 271–282. doi: 10.1006/smim.1993.10318219105
12. Garcia Z, Lemaître F, van Rooijen N, Albert ML, Levy Y, et al. Subcapsular sinus macrophages promote NK cell accumulation and activation in response to lymph-borne viral particles. Blood. 2012; 120: 4744–4750. doi: 10.1182/blood-2012-02-40817923065157
13. Coombes JL, Han SJ, van Rooijen N, Raulet DH, Robey EA, Infection-induced regulation of natural killer cells by macrophages and collagen at the lymph node subcapsular sinus. Cell Rep. 2012; 2: 124–135. doi: 10.1016/j.celrep.2012.06.00122840403
14. Sandberg K, Eloranta ML, Campbell IL, Expression of alpha/beta interferons (IFN-alpha/beta) and their relationship to IFN-alpha/beta-induced genes in lymphocytic choriomeningitis. J Virol. 1994; 68: 7358–7366. 7933119
15. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP, Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol. 1999; 17:189–220. doi: 10.1146/annurev.immunol.17.1.18910358757
16. Carrasco YR, Batista FD, B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity. 2007; 27:160–171. doi: 10.1016/j.immuni.2007.06.00717658276
17. Junt T, Moseman EA, Iannacone M, Massberg S, Lang PA, et al. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature. 2007; 450: 110–114. doi: 10.1038/nature0628717934446
18. Iannacone M, Moseman EA, Tonti E, Bosurgi L, Junt T, Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature. 2010; 465: 1079–1083. doi: 10.1038/nature0911820577213
19. Honke N, Shaabani N, Cadeddu G, Sorg UR, Zhang DE, et al. Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat Immunol. 2011; 13: 51–57. doi: 10.1038/ni.216922101728
20. Hangartner L, Zinkernagel RM, Hengartner H, Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol. 2006; 6: 231–243. doi: 10.1038/nri178316498452
21. Jonjić S, Mutter W, Weiland F, Reddehase MJ, Koszinowski UH, Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. J Exp Med. 1989; 169: 1199–1212. 2564415
22. Frederico B, Chao B, Lawler C, May JS, Stevenson PG, Subcapsular sinus macrophages limit acute gammaherpesvirus dissemination. J Gen Virol. 2015; 96: 2314–2327. doi: 10.1099/vir.0.00014025872742
23. Chong KT, Gresser I, Mims CA, Interferon as a defence mechanism in mouse cytomegalovirus infection. J Gen Virol. 1983; 64:461–464. doi: 10.1099/0022-1317-64-2-4616187894
24. Dutia BM, Allen DJ, Dyson H, Nash AA, Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection. Virology. 1999; 261: 173–179. doi: 10.1006/viro.1999.983410497103
25. Baranek T, Manh TP, Alexandre Y, Maqbool MA, Cabeza JZ, et al. Differential responses of immune cells to type I interferon contribute to host resistance to viral infection. Cell Host Microbe. 2012; 12: 571–584. doi: 10.1016/j.chom.2012.09.00223084923
26. Dağ F, Dölken L, Holzki J, Drabig A, Weingärtner A, et al. Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latency. PLoS Pathog2014; 10: e1003962. doi: 10.1371/journal.ppat.100396224586165
27. Sacher T, Podlech J, Mohr CA, Jordan S, Ruzsics Z, et al. The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host. Cell Host Microbe. 2008; 3: 263–272. doi: 10.1016/j.chom.2008.02.01418407069
28. Frederico B, Chao B, May JS, Belz GT, Stevenson PG, A murid gamma-herpesviruses exploits normal splenic immune communication routes for systemic spread. Cell Host Microbe. 2014; 15: 457–470. doi: 10.1016/j.chom.2014.03.01024721574
29. Swiecki M, Colonna M, The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol. 2015; 15: 471–485. doi: 10.1038/nri386526160613
30. Swiecki M, Gilfillan S, Vermi W, Wang Y, Colonna M, Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8+ T cell accrual. Immunity. 2010; 33: 955–966. doi: 10.1016/j.immuni.2010.11.02021130004
31. Brown MG, Dokun AO, Heusel JW, Smith HR, Beckman DL, et al. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science. 2001; 292: 934–937. doi: 10.1126/science.106004211340207
32. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL, Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 2002; 296: 1323–1326. doi: 10.1126/science.107088411950999
33. Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A. 2002; 99: 8826–8831. doi: 10.1073/pnas.09225859912060703
34. Voigt V, Forbes CA, Tonkin JN, Degli-Esposti MA, Smith HR, et al. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci U S A. 2003; 100: 13483–13488. doi: 10.1073/pnas.223357210014597723
35. Corbett AJ, Coudert JD, Forbes CA, Scalzo AA, Functional consequences of natural sequence variation of murine cytomegalovirus m157 for Ly49 receptor specificity and NK cell activation. J Immunol. 2011; 186: 1713–1722. doi: 10.4049/jimmunol.100330821187440
36. Salazar-Mather TP, Lewis CA, Biron CA, Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1 alpha delivery to the liver. J Clin Investig. 2002; 110: 321–330. doi: 10.1172/JCI1537612163451
37. Kastenmüller W, Torabi-Parizi P, Subramanian N, Lämmermann T, Germain RN, A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell. 2012; 150: 1235–1248. doi: 10.1016/j.cell.2012.07.02122980983
38. Gray EE, Cyster JG, Lymph node macrophages. J Innate Immun. 2012; 4: 424–436. doi: 10.1159/00033700722488251
39. Van Rooijen N, Sanders A, Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods. 1994; 174: 83–93. 8083541
40. Lawler C, Tan CS, Simas JP, Stevenson PG, Type 1 interferons and NK cells restrict gamma-herpesvirus lymph node infection. J Virol. 2016; pii: JVI.01108-16.
41. Shivkumar M, Lawler C, Milho R, Stevenson PG, Herpes simplex virus type 1 interaction with myeloid cells in vivo. J Virol. 2016; pii: JVI.00881-16.
42. Zimmermann A, Trilling M, Wagner M, Wilborn M, Bubic I, et al. A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med. 2005; 201: 1543–1553. doi: 10.1084/jem.2004140115883169
43. Lang PA, Recher M, Honke N, Scheu S, Borkens S, et al. Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice. Hepatology. 2010; 52: 25–32. doi: 10.1002/hep.2364020578253
44. Cervantes-Barragán L, Kalinke U, Züst R, König M, Reizis B, et al. Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection. J Immunol. 2009; 182: 1099–1106. 19124753
45. Hertzog PJ, Hwang SY, Kola I, Role of interferons in the regulation of cell proliferation, differentiation, and development. Mol Repro Dev. 1994; 39: 226–232.
46. Lisnić B, Lisnić VJ, Jonjić S, NK cell interplay with cytomegaloviruses. Curr Opin Virol. 2015; 15:9–18. doi: 10.1016/j.coviro.2015.07.00126208082
47. Farrell HE, Lawler C, Oliveira MT, Davis-Poynter N, Stevenson PG, 2015Alveolar macrophages are a prominent but nonessential target for murine cytomegalovirus infecting the lungs. J Virol. 2015; 90: 2756–2766. doi: 10.1128/JVI.02856-1526719275
48. Gaya M, Castello A, Montaner B, Rogers N, Reis e Sousa C, et al. Host response. Inflammation-induced disruption of SCS macrophages impairs B cell responses to secondary infection. Science. 2015; 347: 667–672. doi: 10.1126/science.aaa130025657250
49. Schroder K, Hertzog PJ, Ravasi T, Hume DA, Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004; 75: 163–189. doi: 10.1189/jlb.060325214525967
50. Hsu KM, Pratt JR, Akers WJ, Achilefu SI, Yokoyama WM, Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J Gen Virol. 2009; 90:33–43. doi: 10.1099/vir.0.006668-019088270
51. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I, Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999; 8: 265–77. 10621974
52. Caton ML, Smith-Raska MR, Reizis B, Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J Exp Med. 2007; 204: 1653–1664. doi: 10.1084/jem.2006264817591855
53. Kamphuis E, Junt T, Waibler Z, Forster R, Kalinke U, Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood. 2006; 108: 3253–3261. doi: 10.1182/blood-2006-06-02759916868248
54. Farrell HE, Lawler C, Tan CSE, MacDonald K, Bruce K, et al. Murine cytomegalovirus exploits olfaction to enter new hosts. MBio. 2016; 7: e00251–16. doi: 10.1128/mBio.00251-1627118588
55. Trgovcich J, Stimac D, Polic B, Krmpotic A, Pernjak-Pugel E, et al. Immune responses and cytokine induction in the development of severe hepatitis during acute infections with murine cytomegalovirus. Arch Virol. 2000; 145: 2601–2618. 11205107